Associations among Darbepoetin-α, CD34+ Cells and Cardiovascular Disease Events in Patients on Hemodialysis

Publisher： Karger

E-ISSN： 1664-5529|2|1|233-246

ISSN： 1664-5529

Source： Nephron Extra, Vol.2, Iss.1, 2012-09, pp. : 233-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?

By  

Cardiorenal Medicine, Vol. 2, Iss. 1, 2011-12 ,pp. : 18-25

Karger

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease Proven by Transient Elastography in Hemodialysis Patients: Is It a New Risk Factor for Adverse Cardiovascular Events?

By  

Blood Purification, Vol. 37, Iss. 4, 2014-07 ,pp. : 259-265

Karger

Access to resources Recommend Favorite

Circulating Endothelial Progenitor Cell Levels Predict Cardiovascular Events in End-Stage Renal Disease Patients on Maintenance Hemodialysis

By  

Nephron, Vol. 130, Iss. 3, 2015-06 ,pp. : 151-158

Karger

Access to resources Recommend Favorite

Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 4, 2012-01 ,pp. : 247-253

Karger

Access to resources Recommend Favorite

Homocysteine-Lowering Vitamin B Treatment Decreases Cardiovascular Events in Hemodialysis Patients

By  

Blood Purification, Vol. 24, Iss. 4, 2006-08 ,pp. : 379-386

Karger

Access to resources Recommend Favorite